Need more insight?
Speak to us about commissioning some bespoke research.
Find out moreBig Health overview
Big Health is a developer of personalised and fully automated behavioural medicine programs.
Designed by leading clinical experts, Big Health's solutions feature cognitive and behavioural techniques. Its solutions include Sleepio, for helping individuals address poor sleep, and Daylight for helping individuals address worry and anxiety.
More than 12 million people across 60+ countries have access to Sleepio and Daylight, with Big Health's clients including Target and Home Deport.
In June 2020 the company raised a $39m Series B, led by Glide Healthcare and Morningside Ventures.
In July 2023 Big Health acquired Limbix, a creator of digital therapeutics for teenage mental health. The transaction expands Big Health’s portfolio of existing products, including Sleepio for insomnia and Daylight along with another adolescent product in development targeting anxiety. SparkRx uses self-guided cognitive behavioural therapy on smartphones, providing skills such as mood tracking and problem-solving. The addition of SparkRx helps address the growing demand for mental healthcare solutions among employers and insurers. More than 300k patients have enrolled in treatment through Big Health’s digital therapeutics.
Big Health has offices in both San Francisco and London.
Map showing the location of Big Health
San Francisco,
United States
Key people
Arun Gupta
Board Member
Charlotte Lee
UK Director
Ophelia Brown
Board Observer
Colin Espie
Co-Founder & Chief Medical Officer
Peter Hames
Co-Founder & CEO
Neil Rimer
Member, Board Of Directors
Liz Rockett
Board Member
Sarah Pedersen
Vice President, Customer Success
Ankur Kaushal
Vice President, Regulatory Affairs & Quality Assurance
Shawn Zhou
Director of Partnerships
Dickon Waterfield
Advisor
Janke Dittmer
Board Member
Isaac Cheng
Board Member
John Hallock
Advisor
Alliott Cole
Board Member
Mark Edgeworth
GtM Advisor
John Cassidy
Board Member